|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 35/761 | (2015.01) |
| C12N 15/86 | (2006.01) | ||
| C07K 14/705 | (2006.01) |
| (11) | Number of the document | 3288573 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16723043.2 |
| Date of filing the European patent application | 2016-04-29 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation | 2020-03-25 |
| (86) | Number | PCT/EP2016/059609 |
| Date | 2016-04-29 |
| (87) | Number | WO 2016/174200 |
| Date | 2016-11-03 |
| (30) | Number | Date | Country code |
| 201507419 | 2015-04-30 | GB | |
| 201516936 | 2015-09-24 | GB | |
| 201522013 | 2015-12-14 | GB |
| (72) |
CHAMPION, Brian Robert, GB
BROMLEY, Alice Claire Noel, GB
|
| (73) |
AKAMIS BIO LIMITED,
Akamis House 4-10 the Quadrant, Barton Lane, Abingdon, Oxfordshire, OX14 3YS,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Onkolitinis adenovirusas, koduojantis B7 baltymą |
| ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN |
| Payment date | Validity (years) | Amount | |
| 2025-04-01 | 10 | 231.00 EUR |
| 2026-04-29 |